Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

BioLegend

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
San Diego, California, United States Founded 2002 501-1000 employees For Profit

BioLegend is a biotechnology firm that offers immunological reagents for biomedical research.

BioLegend on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

BioLegend was acquired by PerkinElmer in 2021 for $5.25B.
Last Funding
Acquisitions
0
Monthly Visits
Contacts
480
Patents
48
5 trademarks

About BioLegend

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
14
Mobile apps
3
Active products
17
Patents granted
48
Trademarks
5
Top patent class
Testing
IT spend
$6.97M

Company Info

Founded
2002
Employees
501-1000
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
35
HQ
San Diego, California, United States
Region
Greater San Diego Area, West Coast, Western US
Exit date
Jul 26, 2021

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
2.4
Trend (90d)
-0.3

BioLegend Key People

President and CEO
Vice President Research And Development
480
professional contacts at BioLegend
Contact execs at BioLegend

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to BioLegend

Loading news…

FAQs about BioLegend

People who checked this page also checked these

Browse the full Acquirezy directory.
BioLegend — Company Profile